Evidence map›Paper›PMID 20237040›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2010

Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

Robert K Doot, Mark Muzi, Lanell M Peterson, Erin K Schubert, Julie R Gralow, Jennifer M Specht, David A Mankoff

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [European journal of nuclear medicine and molecular imaging · 2019
    Trial
  3. Trial
  4. Imaging of Bone Metastases in Breast Cancer.Seminars in nuclear medicine · 2022
    Review
  5. Article
  6. Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Article
  7. Article
  8. Functional and Hybrid Imaging of Bone Metastases.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Review
  9. Site specific measurements of bone formation using [Quantitative imaging in medicine and surgery · 2018
    Review
  10. Predictive value of [European journal of nuclear medicine and molecular imaging · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using (18)F-NaF.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2014
    Article
  16. Article
  17. The isotope bone scan: we can do better.European journal of nuclear medicine and molecular imaging · 2013
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Robert K DootDivision of Nuclear Medicine, University of Washington and Seattle Cancer Care Alliance, Seattle, Washington 98195-7987, USA. bdoot@uw.edu
Mark Muzi
Lanell M Peterson
Erin K Schubert
Julie R Gralow
Jennifer M Specht
David A Mankoff
Seattle Cancer Care Alliance · USUniversity of Washington · US

Funding

RadiochemistryP01CA042045 · NCI · UNIVERSITY OF WASHINGTON · PI LINK, JEANNE MEYERS · 1986 to 2015
$23.2M
IMAGING THE RESPONSE OF LOCALLY ADVANCED BREAST CANCERR01CA072064 · NCI · UNIVERSITY OF WASHINGTON · PI MANKOFF, DAVID A. · 1996 to 2006
$3.1M
PET to Measure Breast Cancer Bone Metastasis ResponseR01CA124573 · NCI · UNIVERSITY OF WASHINGTON · PI SPECHT, JENNIFER MARIE · 2007 to 2011
$1.8M
Cyclotron for PET Isotope ProductionS10RR017229 · NCRR · UNIVERSITY OF WASHINGTON · PI KROHN, KENNETH A. · 2002 to 2002
$1.6M
NCI NIH HHS CA124573NCI NIH HHS CA72064NCI NIH HHS P01 CA042045NCI NIH HHS R01 CA072064NCI NIH HHS R01 CA124573NCRR NIH HHS RR17229NCRR NIH HHS S10 RR017229
6 · The paper itself

Abstract

unlabelledThe most common site of metastasis for breast cancer is bone. Quantitative (18)F-fluoride PET can estimate the kinetics of fluoride incorporation into bone as a measure of fluoride transport, bone formation, and turnover. The purpose of this analysis was to evaluate the accuracy and precision of (18)F-fluoride model parameter estimates for characterizing regional kinetics in metastases and normal bone in breast cancer patients.

methodsTwenty metastatic breast cancer patients underwent dynamic (18)F-fluoride PET. Mean activity concentrations were measured from serial blood samples and regions of interest placed over bone metastases, normal vertebrae, and cardiac blood pools. This study examined parameter identifiability, model sensitivity, error, and accuracy using parametric values from the patient cohort.

resultsRepresentative time-activity curves and model parameter ranges were obtained from the patient cohort. Model behavior analyses of these data indicated (18)F-fluoride transport and flux (K(1) and Ki, respectively) into metastatic and normal osseous tissue could be independently estimated with a reasonable bias of 9% or less and reasonable precision (coefficients of variation <or= 16%). Average (18)F-fluoride transport and flux into metastases from 20 patients (K(1) = 0.17 +/- 0.08 mL x cm(-3) x min(-1) and Ki = 0.10 +/- 0.05 mL x cm(-3) x min(-1)) were both significantly higher than for normal bone (K(1) = 0.09 +/- 0.03 mL x cm(-3) x min(-1) and Ki = 0.05 +/- 0.02 mL x cm(-3) x min(-1), P < 0.001).

conclusionFluoride transport and flux can be accurately and independently estimated for bone metastases and normal vertebrae. Reasonable bias and precision for estimates of K(1) and Ki from simulations and significant differences in values from patient modeling results in metastases and normal bone suggest that (18)F-fluoride PET images may be useful for assessing changes in bone turnover in response to therapy. Future studies will examine the correlation of parameters to biologic features of bone metastases and to response to therapy.

Indexed as

Positron-Emission TomographyAdultAgedAnalysis of VarianceBiological TransportBiomarkers, TumorBone NeoplasmsBreast NeoplasmsFemaleFluoridesFluorine RadioisotopesHumansKineticsMaleMiddle AgedSensitivity and SpecificityBiomarkers, TumorFluoridesFluorine Radioisotopes

Identifiers

PMID20237040
PMCPMC3063528
OpenAlexW2152935357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.